New LMU Munich Study on the Importance of the Microbiome in MS
The connection between autoimmune inflammation and the gut microbiome has sparked great interest in the
Continue readingThe connection between autoimmune inflammation and the gut microbiome has sparked great interest in the MS community in recent years. There is now interesting news on this topic: The Institute for Clinical Neuroimmunology at the
Continue readingIn this second video of the three-part series “Cortisone in MS”, Prof. Mathias Mäurer explains what possible side effects cortisone can have in MS, what can be done against it and why the question of
Continue readingIn this video of the three-part series “Corticosteroids in MS,” Prof. Mathias Mäurer explains what corticosteroids are, how they are used in multiple sclerosis, when corticosteroids are used in MS, what effect they have on
Continue readingWe roughly distinguish two different classes of MS drugs. On the one hand, the so-called basic therapies, which can be given in cases of mild/moderate MS, and on the other hand, the highly effective therapies
Continue readingThe annual meeting of the American Academy of Neurology (AAN) is the largest neurological congress worldwide and covers all sub-areas of neurology. The AAN is not necessarily the most important meeting for the discussion of
Continue readingWhen one looks at the progress made in “large language models” such as ChatGPT, one cannot help but be amazed. Questions from all areas of life are answered reliably and linguistically sophisticated within seconds. Even
Continue readingI don’t want to come across as a know-it-all at this point. But after my remarks on the Mollii Suit have caused excitement, I would like to briefly address the most recent court rulings on
Continue readingI have posted several articles on the topic of pregnancy and MS, to which I would also like to refer here (e.g. Pregnancy and breastfeeding). There were now some interesting news on this topic at
Continue readingWhere does conventional medicine end, where do alternative healing methods begin? This article and video deal with evidence-based medicine, alternative methods and the role of the psyche in the development of MS. Prof. Mathias Mäurer
Continue readingAt this year’s ECTRIMS Meeting in Copenhagen, the data from the study program of the Bruton-Tyrosine-Kinase (BTK) inhibitor Tolebrutinib was presented. And what can I say – fortunately there were positive news this time.
Continue readingUnsere Website verwendet Cookies und sammelt dabei Informationen über Ihren Besuch, um unsere Website zu verbessern (durch Analyse), Ihnen Social Media-Inhalte und relevante Werbung anzuzeigen. Weitere Informationen finden Sie auf unserer Seite . Sie können zustimmen, indem Sie auf die Schaltfläche "Akzeptieren" klicken.
Cookie-Einstellungen
Unten können Sie auswählen, welche Art von Cookies Sie auf dieser Website zulassen. Klicken Sie auf die Schaltfläche "Cookie-Einstellungen speichern", um Ihre Auswahl zu übernehmen.
Dieser Inhalt ist gesperrt. Akzeptieren Sie Cookies in der Kategorie '%CC%', um diesen Inhalt anzuzeigen.